Operating income increased 67.6%
Operating income changed +67.6% from the comparable as-filed period.
$383.7M→$642.9M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SNX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue increased 37.7%
Revenue changed +37.7% from the comparable as-filed period.
$15.7B→$21.6B2 prior comparisons
Net debt increased 31.2%
Net debt changed +31.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$2.2B→$2.8B4 prior comparisons
Cost of revenue increased 38.6%
Cost of revenue changed +38.6% from the comparable as-filed period.
$14.5B→$20.1B2 prior comparisons
Net income increased 83.5%
Net income changed +83.5% from the comparable as-filed period.
$226.8M→$416.2M2 prior comparisons
Inventory / revenue moved 1255 bp higher
Inventory / revenue changed +1255 basis points from the comparable as-filed period.
58.38%→70.93%2 prior comparisons
Debt / assets moved 287 bp lower
Debt / assets changed -287 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
12.20%→9.33%4 prior comparisons
Revenue increased 31.0%
Revenue changed +31.0% from the comparable as-filed period.
$14.9B→$19.6B2 prior comparisons
Operating income increased 58.3%
Operating income changed +58.3% from the comparable as-filed period.
$328.1M→$519.4M2 prior comparisons
Cost of revenue increased 31.2%
Cost of revenue changed +31.2% from the comparable as-filed period.
$13.9B→$18.2B2 prior comparisons
Net income increased 80.7%
Net income changed +80.7% from the comparable as-filed period.
$184.9M→$334.1M2 prior comparisons
Inventory / revenue moved 1307 bp higher
Inventory / revenue changed +1307 basis points from the comparable as-filed period.
57.91%→70.98%2 prior comparisons
Cash & equivalents increased 42.6%
Cash & equivalents changed +42.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$767.1M→$1.1B4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.